What is the proper way to administer phenytoin intravenously using an infusion set?

Phenytoin Intravenous Administration via Infusion Set

Phenytoin must be diluted in normal saline only (never dextrose), administered at ≤50 mg/min in adults or ≤1-3 mg/kg/min in children through a large-bore peripheral or central catheter, with continuous cardiac monitoring and immediate saline flush before and after administration. 1

Critical Administration Requirements

Dilution and Preparation

• Dilute only in 0.9% normal saline – never use dextrose-containing solutions as phenytoin will precipitate 1
• Final concentration must be ≥5 mg/mL 1
• Use an in-line filter (0.22-0.55 microns) 1
• Administer immediately after preparation – must complete within 1-4 hours 1
• Do not refrigerate the diluted mixture 1

Infusion Rate (Critical for Safety)

• Adults: Maximum 50 mg/min 1
• Pediatric patients: Maximum 1-3 mg/kg/min OR 50 mg/min, whichever is slower 1
• Neonates: Drug delivery rate not to exceed 1 mg/kg/min 2

The slower pediatric rate is essential because rapid administration causes hypotension, bradyarrhythmias, and cardiac arrest 2, 1.

Vascular Access and Technique

• Use a large-gauge catheter in a large peripheral or central vein 1
• Test catheter patency with sterile saline flush before phenytoin administration 1
• Flush with sterile saline immediately after phenytoin to prevent local venous irritation from alkaline pH 1
• Avoid small peripheral veins due to risk of Purple Glove Syndrome (soft tissue necrosis, edema, discoloration) 1

Dosing for Status Epilepticus

Pediatric Dosing

• Loading dose: 15-20 mg/kg IV 2, 3, 1
• Maximum initial dose: 1000 mg 2
• Infusion time: 10-20 minutes 2

Adult Dosing

• Loading dose: 10-15 mg/kg IV 1
• Approximately 20 minutes required for a 70-kg patient at maximum safe rate 1

Essential Monitoring

Continuous cardiac monitoring is mandatory during and after infusion 1:

• Monitor heart rate – reduce infusion rate if heart rate decreases by 10 beats/min 2
• Watch for hypotension and arrhythmias 2, 1
• Be prepared to provide respiratory support, especially when combined with benzodiazepines 2

Critical Safety Considerations

Cardiovascular Toxicity

Rapid infusion causes:

• Hypotension
• Bradyarrhythmias
• Cardiac arrest 2, 1, 4

If cardiovascular complications occur: Immediately slow or temporarily stop the infusion 4. Complications resolve promptly with rate reduction 4.

Local Toxicity Prevention

• Burning pain at IV site occurs in approximately 45% of patients 5
• Reduce infusion rate to 20 mg/min if burning occurs 6
• Purple Glove Syndrome can develop days after injection and may require fasciotomy or amputation in severe cases 1

Special Populations

Neonates: Higher risk of toxicity due to decreased protein binding – phenobarbital is preferred 2. If phenytoin is used, expect free phenytoin levels of 8-13% of total (similar to adults) but require higher doses (10-20 mg/kg/day orally for maintenance) 7.

Practical Infusion Protocol

1. Prepare: Dilute phenytoin in normal saline (≥5 mg/mL concentration)
2. Prime: Flush IV catheter with sterile saline to confirm patency
3. Connect: Use in-line 0.22-0.55 micron filter
4. Monitor: Initiate continuous cardiac monitoring
5. Infuse: Begin at appropriate rate (≤50 mg/min adults; ≤1-3 mg/kg/min children)
6. Observe: Check vital signs and rhythm every 15 minutes 6
7. Adjust: Reduce rate if heart rate drops ≥10 bpm or burning occurs
8. Flush: Immediately flush catheter with sterile saline after completion

Important Alternatives

Fosphenytoin is strongly preferred when available because it has lower risk of adverse cardiac effects and can be administered faster (150 PE/min vs 50 mg/min) 2, 3. Fosphenytoin can also be given intramuscularly, unlike phenytoin 3.